In this research article published in the journal Toxicon: X, authors from MSF and the Pasteur Institute of Central African Republic present MSF activities and experience treating people for snakebite. MSF treats over 7,000 cases of snakebite each year, predominantly in Central African Republic, Ethiopia, South Sudan and Yemen. Regular training on clinical protocols is essential to ensure correct choice of antivenom based on syndrome. Offering antivenom free of charge is essential to improve access to care, although it is costly for MSF. MSF provides other services such as surgery and, less systematically, health promotion at community level. Improving post-discharge care for sequelae, including mental health care, is a priority.
